Item
FUFENG XANTHAN RD JILI. (6227523 400 01M)
Stabilizer / Thickener / Binder / Texturizers
Attributes
- Gluten-free
- Halal
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
Location name | Address |
---|---|
JILIN PHARMA USA INC - MITSUBISHI | Jing Er Rd., Jinchuan District Economic Development Zone Hohhot City, lnner Mongolia Autonomous Region 0 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Lot Code | JILIN PHARMA USA INC - MITSUBISHI | 2019 Lot Code Explanation.pdf | 6/26/2024 | 6/26/2027 |
Allergens | JILIN PHARMA USA INC - MITSUBISHI | Allergens.pdf | 7/21/2022 | 7/20/2024 |
BSE - TSE | JILIN PHARMA USA INC - MITSUBISHI | BSE-TSE Statement.pdf | 6/14/2022 | 6/13/2025 |
CoA Sample | JILIN PHARMA USA INC - MITSUBISHI | Certificate of Analysis - COA.pdf | 3/23/2021 | 3/23/2023 |
Country of Origin | JILIN PHARMA USA INC - MITSUBISHI | Country of Origin.pdf | 7/21/2022 | 7/20/2025 |
Dietary Supplement Questionnaire | JILIN PHARMA USA INC - MITSUBISHI | Dietary Supplement Questionnaire.pdf | 1/14/2024 | 1/13/2025 |
EtO Statement | JILIN PHARMA USA INC - MITSUBISHI | ETO Statement.pdf | 7/31/2021 | 7/31/2023 |
Food Contact Packaging Certificate of Compliance | JILIN PHARMA USA INC - MITSUBISHI | Food Packaging Statement.pdf | 6/14/2022 | 6/13/2024 |
HARPC Food Safety Plan (Item) | JILIN PHARMA USA INC - MITSUBISHI | Food Safety Management Certificate.pdf | 1/14/2024 | 1/13/2027 |
FSVP Assessment Form | JILIN PHARMA USA INC - MITSUBISHI | FSVP Assessment Form.pdf | 1/14/2024 | 1/13/2025 |
Gluten | JILIN PHARMA USA INC - MITSUBISHI | Gluten Free Statement.pdf | 6/1/2023 | 5/31/2025 |
GRAS/NDI/ODI Statement | JILIN PHARMA USA INC - MITSUBISHI | GRAS and Food Statement.pdf | 6/26/2024 | 6/26/2027 |
HACCP Process Flow Diagram | JILIN PHARMA USA INC - MITSUBISHI | HACCP Flow Chart.pdf | 1/23/2024 | 1/22/2026 |
HACCP | JILIN PHARMA USA INC - MITSUBISHI | HACCP Plan.pdf | 8/8/2021 | 8/7/2024 |
Halal | JILIN PHARMA USA INC - MITSUBISHI | Halal Certificate 2022.pdf | 10/18/2021 | 11/28/2024 |
Heavy Metal | JILIN PHARMA USA INC - MITSUBISHI | Heavy Metal Statement.pdf | 6/14/2022 | 6/13/2024 |
Ingredient Statement | JILIN PHARMA USA INC - MITSUBISHI | Ingredient and Composition Formula Statement.pdf | 1/1/2022 | 1/1/2023 |
GMO | JILIN PHARMA USA INC - MITSUBISHI | IP Certificate.pdf | 6/28/2023 | 6/27/2025 |
Item Questionnaire | JILIN PHARMA USA INC - MITSUBISHI | Item Questionnaire.pdf | 7/22/2022 | 7/21/2025 |
Kosher | JILIN PHARMA USA INC - MITSUBISHI | Kosher Certificate 022825.pdf | 2/27/2024 | 2/28/2025 |
Melamine | JILIN PHARMA USA INC - MITSUBISHI | Melamine Free Statement.pdf | 6/10/2022 | 6/10/2023 |
National Bioengineered Food Disclosure Standard (Simplified) | JILIN PHARMA USA INC - MITSUBISHI | National Bioengineered Food Disclosure Standard (Simplified).pdf | 7/22/2022 | 7/21/2025 |
Natural | JILIN PHARMA USA INC - MITSUBISHI | Natural Statement.pdf | 6/14/2022 | 6/14/2023 |
No Animal Ingredient Statement | JILIN PHARMA USA INC - MITSUBISHI | Non-Animal Ingredient Statement.pdf | 6/14/2022 | 6/14/2023 |
Animal Testing Statement | JILIN PHARMA USA INC - MITSUBISHI | Non-Animal Testing Statement.pdf | 6/10/2022 | 6/9/2024 |
Irradiation Status Statement | JILIN PHARMA USA INC - MITSUBISHI | Non-Irradiation Statement.pdf | 6/10/2022 | 6/9/2024 |
Sewage Statement | JILIN PHARMA USA INC - MITSUBISHI | Non-Sewage Statement.pdf | 6/14/2022 | 6/13/2024 |
Label Claims | JILIN PHARMA USA INC - MITSUBISHI | NotApplicable_LabelClaims.pdf | 7/20/2022 | 7/19/2024 |
Label Guidance | JILIN PHARMA USA INC - MITSUBISHI | NotApplicable_LabelGuidance.pdf | 7/20/2022 | 7/19/2024 |
Nutrition | JILIN PHARMA USA INC - MITSUBISHI | Nutrition.pdf | 8/14/2024 | 8/14/2027 |
Pesticide | JILIN PHARMA USA INC - MITSUBISHI | Pesticide Free Statement.pdf | 6/14/2022 | 6/13/2024 |
Phthalate Esters Letter | JILIN PHARMA USA INC - MITSUBISHI | Phthalate Esters Statement.pdf | 6/14/2022 | 6/14/2023 |
Label Sample | JILIN PHARMA USA INC - MITSUBISHI | Product Label.pdf | 1/14/2024 | 1/13/2025 |
California Prop. 65 | JILIN PHARMA USA INC - MITSUBISHI | Proposition 65 Statement.pdf | 6/14/2022 | 6/13/2024 |
Residual Statement | JILIN PHARMA USA INC - MITSUBISHI | Residual Solvent Statement.pdf | 6/14/2022 | 6/14/2023 |
Safety Data Sheet (SDS) | JILIN PHARMA USA INC - MITSUBISHI | Safety Data Sheet - Xanthan Gum 2021.pdf | 6/26/2024 | 6/26/2027 |
Shelf Life | JILIN PHARMA USA INC - MITSUBISHI | Shelf-Life and Storage Conditions.pdf | 1/1/2022 | 12/31/2024 |
Product Specification Sheet | JILIN PHARMA USA INC - MITSUBISHI | Specifications.pdf | 8/23/2021 | 8/22/2024 |
Suitability Requirements | JILIN PHARMA USA INC - MITSUBISHI | Suitability Requirements.pdf | 7/22/2022 | 7/21/2025 |
WADA/NSF/NFL Statement | JILIN PHARMA USA INC - MITSUBISHI | WADA-NSF-NFL Statement.pdf | 6/14/2022 | 6/13/2024 |
Organic | JILIN PHARMA USA INC - MITSUBISHI | Xanthan Gum - Organic Compliance.pdf | 6/27/2021 | 6/27/2024 |